Astarabine, a pro-drug of cytarabine, is safe for patients with advanced acute leukemia. A phase I/IIa single center study in relapsed/refractory or medically unfit patients Meeting Abstract
| Authors: | Zuckerman, T.; Ben Yakar, R.; Gengrinovitch, S.; Hoffman, R.; Henig, I.; Lavi, N.; Akria, L.; Ofran, Y.; Nudelman, O.; Haddad, N.; Tallman, M. S.; Rowe, J. M. |
| Abstract Title: | Astarabine, a pro-drug of cytarabine, is safe for patients with advanced acute leukemia. A phase I/IIa single center study in relapsed/refractory or medically unfit patients |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368021800067 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.3810.3810 |
| Notes: | Meeting Abstract: 3810 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
